A Day Late and a Billion Dollars Short: Will the Medicines Co. Get to Keep its Patent?
In 2001, the Medicines Company just missed the application deadline for a patent extension for its main product, Angiomax, a…
In 2001, the Medicines Company just missed the application deadline for a patent extension for its main product, Angiomax, a…